Publication | Closed Access

A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)

MedicineCancer ManagementGynecologyTopotecan RegimensPhase Ii StudyGog 146QCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian Cancer